Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Olimel N12-640 |
| Component 1: | |
| Active Ingredients: |
Alanine 20.6g/L |
| Dosage Form: | Emulsion for infusion |
| Component 2: | |
| Active Ingredient: | Glucose monohydrate 302.5g/L equivalent to glucose anhydrous 275g/L |
| Dosage Form: | Emulsion for infusion |
| Component 3: | |
| Active Ingredients: | Olive oil 140g/L Soya oil 35g/L |
| Dosage Form: | Emulsion for infusion |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Baxter SA, Lessines, Belgium |
| Product: | Olimel N12-640E |
| Component 1: | |
| Active Ingredients: |
Alanine 20.6g/L |
| Dosage Form: | Emulsion for infusion |
| Component 2: | |
| Active Ingredients: | Calcium chloride dihydrate 1.94g/L Glucose monohydrate 302.5g/L equivalent to glucose anhydrous 275.0g/L |
| Dosage Form: | Emulsion for infusion |
| Component 3: | |
| Active Ingredients: | Olive oil 140g/L Soya oil 35g/L |
| Dosage Form: | Emulsion for infusion |
| New Zealand Sponsor: | Baxter Healthcare Limited |
| Manufacturer: | Baxter SA, Lessines, Belgium |
Dated this 15th day of September 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).